The National Pension of Service of Korea (NPS) increased or reduced its stake in six listed pharmaceutical companies by more than 1% in the fourth quarter of 2021.
According to new data from the NPS on the 5th, the NPS expanded its shares in Daewoong Pharmaceutical and ST Pharm by more than 1% in the fourth quarter.
In August, the NPS became a shareholder of 5% or more of ST Pharm, and its share rose 1.08%p to 6.11%, and Daewoong Pharmaceutical’s 1.00%p from 6.14% to 7.14%.
On the other hand, the stake in Chong Kun Dang Holdings, Handok, Bukwang Pharmaceutical, and Il-Yang Pharmaceutical decreased by more than 1%p.
The stake in Chong Kun Dang Holdings fell to a single digit (10.49% → 9.48%) in August last year and 1.02%p to 8.46% in the fourth quarter.
Handok also lost 1.00%p from 7.67% to 6.67%, while Bukwang Pharmaceutical also fell 1.03%p from 7.06% to 6.03%.
The NPS resigned from more than 5% of Il-Yang Pharmaceutical by 1.05%p from 5.05% to 4.00%.
